Finished
The Influence of Perioperative Administration of Dexmedetomidine on Inflammation Response and Postoperative Recovery in Patients Undergoing Robot or Laparoscopic Assisted Gastrectomy
NCT03960775 · Yonsei University · Updated 28 Sept 2020
- What is being tested
- dexmedetomidine; saline
- For
- Gastric Cancer; Gastrostomy
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 20 years to 70 years. About 84 people. The full rules are on the registry page.
- Where
- South Korea
- When
- Starts or started 30 April 2019, ends 29 Nov 2019. Registered 23 May 2019.
- Results
- None posted yet.
In the researchers' words
Many studies have shown that inflammation has an important effect on the development, progression, and also response to treatment of tumors. Dexmedetomidine is a potent and selective alpha 2 receptor agonist, known to have a sedative, analgesic and immune-controlling effect. The purpose of this study is to investigate the effect of dexmedetomidine during surgery on postoperative inflammatory response and surgical recovery in gastric cancer patients undergoing robot or laparoscopic gastrectomy.
Sites
- Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of MedicineSeoul, South Korea